Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Randomized Study to Evaluate the Effect of an "Inclisiran First" Implementation Strategy Compared to Usual Care in Patients With Atherosclerotic Cardiovascular Disease and Elevated LDL-C Despite Receiving Maximally Tolerated Statin Therapy (VICTORION-INITIATE)

ClinicalTrials.gov ID: NCT04929249

Public ClinicalTrials.gov record NCT04929249. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 3:52 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Multicenter, Open-label Trial Comparing the Effectiveness of an "Inclisiran First" Implementation Strategy to Usual Care on LDL Cholesterol (LDL-C) in Patients With Atherosclerotic Cardiovascular Disease and Elevated LDL-C (≥70 mg/dL) Despite Receiving Maximally Tolerated Statin Therapy (VICTORION-INITIATE)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study was to assess the effectiveness of an "inclisiran first" implementation strategy (addition of inclisiran to maximally tolerated statin therapy immediately upon failure to achieve acceptable LDL-C with maximally tolerated statin therapy alone) compared to usual care in an atherosclerotic cardiovascular disease (ASCVD) population.

Study identification

NCT ID
NCT04929249
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
450 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 25, 2021 (Actual)
Primary completion
Sep 15, 2023 (Actual)
Completion
Sep 15, 2023 (Actual)
Last update posted
May 16, 2025

2021 – 2023

United States locations

U.S. sites
43
U.S. states
18
U.S. cities
35
Facility City State ZIP Site status
ARcare Center for Clinical Research . Little Rock Arkansas 72205 —
ARcare Center for Clinical Research Little Rock Arkansas 72205 —
Keck Medical Center USC . Los Angeles California 90033 —
d-b-a Greenwich Cardio Assoc CLCZ696BUS08 Greenwich Connecticut 06830 —
Cardiology Ass of Fairfield County . Stamford Connecticut 06905 —
Integrative Research Associates Inc Fort Lauderdale Florida 33312 —
Elite Cardiac Research Center . Hialeah Florida 33012 —
University of Florida Health Science Center . Jacksonville Florida 32209 —
Jacksonville Ctr for Clin Rea Encore Research Group Jacksonville Florida 32216 —
Internal Medicine and Cardiology Kissimmee Florida 34741 —
Gateway Cardiology PC CACZ885M2301_Younis Jerseyville Illinois 62052 —
Affinity Health Corp Oak Brook Illinois 60523 —
Northwestern Medicine Northwestern University . Winfield Illinois 60190 —
Indiana University Health Indianapolis Indiana 46202 —
St Elizabeth Healthcare . Edgewood Kentucky 41017 —
Alexandria Cardiology Clinic . Alexandria Louisiana 71301 —
Medstar Health Research Institute . Baltimore Maryland 21218 —
MedStar Good Samaritan Hospital Baltimore Maryland 21239 —
Bryan LGH Heart Inst Intigrated Cardiology Group . Lincoln Nebraska 68506 —
Inspira Health Network The Heart House Elmer New Jersey 08318 —
New Jersey Heart Linden New Jersey 07036 —
New York Presbyterian Queens . Flushing New York 11355 —
New York Presbyterian Hospital . New York New York 10021 —
State Uni of NY at Stony Brook . Stony Brook New York 11794-3362 —
Montefiore Hospital . The Bronx New York 10467 2490 —
Milton S Hershey Medical Center Hershey Pennsylvania 17033 —
Capital Area Research LLC Suite 330 Newport Pennsylvania 17074 —
Capital Area Research Newport Pennsylvania 17074 —
Cardiology Consultants of Philadelphia Yardley Pennsylvania 19067 —
Alliance for Multispecialty Res LLC Nashville Tennessee 37203 —
Cypress Heart and Vascular Center Cypress Texas 77429 —
NW Houston Neuro Comp Sleep Med Ctr Cypress Texas 77429 —
Primecare Medical Group Houston Texas 77024 —
Synergy Group Medical LLC . Houston Texas 77061 —
Synergy Group Medical LLC Houston Texas 77061 —
Northwest Houston Cardiology PA . Houston Texas 77070 —
Synergy Groups Medical LLC Missouri City Texas 77459 —
Bay Area Heart Ace Clinical Resh Gp . Webster Texas 77598 —
Centra Health . Lynchburg Virginia 24501 —
National Clinical Research . Richmond Virginia 23294 —
Exemplar Research Inc . Morgantown West Virginia 26501 —
Marshfield Medical Clinic . Marshfield Wisconsin 54449 —
Marshfield Clinic Health System Weston Wisconsin 54476 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04929249, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 16, 2025 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04929249 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →